This is notification that the fortieth issue of the Virtual Journal Club (VJC) is available on the International Society of Oncology Pharmacy Practitioners (ISOPP) website. To access it, visit the Virtual Journal Club Surveys page or follow the direct link to the survey.
"Feasibility of Extended Dosing Intervals of Denosumab"
Jacob K Kettle and Puja B Patel
Journal of Oncology Pharmacy Practice (JOPP) published April 9, 2017
Learning Objectives:
- Define skeletal related events;
- Describe the importance of bone targeting agents for prevention of skeletal related events;
- Describe some challenges to maintaining patient adherence on bone targeting agent therapy;
- Understand the implications of the ZOOM trial on dosing intervals for zoledronic acid and the clinical settings in which there is supportive data for extended interval dosing; and
- Gain insight into the importance of maintaining compliance approved dosing intervals with with denosumab.
Accessing JOPP is easy. Log in as a member, go to the JOPP Access page and click the Access JOPP button. You have instant access.
As a reminder, ISOPP's Virtual Journal Club features online articles from the Journal of Oncology Pharmacy Practice (JOPP). Members are encouraged to read articles and then answer a series of multiple choice questions through the Virtual Journal Club Surveys.
After completing the questionnaire, a certificate will be emailed to you. Although not formally accredited for continuing medical education (CME) points, participation is equal to one hour of CME activity.
Members are also encouraged to use the Member Discussion Forum to stimulate discussion about articles they have read. Your ISOPP membership provides many great benefits and we are hopeful you will find the Virtual Journal Club another asset to your oncology pharmacy practice.